Medical device company QT Imaging Holdings Inc (Nasdaq:QTI) announced on Wednesday the launch of the QT Imaging-Olea Viewer, developed in collaboration with Olea Medical, a leader in advanced imaging software solutions.

The viewer provides a unified platform for multiple breast imaging modalities, enabling clinicians to correlate findings across imaging sources and monitor patients longitudinally. It is designed to reduce reliance on multiple software viewers, streamline clinical workflows, and improve efficiency in patient management over time.

QT Imaging's Breast Acoustic CT system uses ultrasound tomography to deliver 3D volumetric breast imaging without ionising radiation or compression, with particular utility in dense breast tissue.

Powered by Olea Medical's visualisation framework, the platform supports advanced 3D rendering, quantitative assessment, and planned AI and machine learning capabilities, including automated lesion segmentation and computer-aided detection.

Product demonstrations will be available at the SBI Breast Imaging Symposium in Seattle.

The collaboration between QT Imaging and Olea Medical, a Canon Medical Systems Corporation company, was announced in January 2026.